\n
Affiliations:<\/strong><\/span><\/p>\n Objective<\/strong><\/p>\n Telehealth has become a transformative force in prenatal care, enhancing maternal satisfaction, reducing costs, and increasing efficiency without compromising safety or outcomes. The Pulsenmore home ultrasound is a handheld device connected to smartphones and guided by a mobile app, enables women to perform high-quality ultrasound scans at home. These scans are securely transmitted to clinicians, enabling a hybrid care model that combines remote monitoring with in-clinic expertise.<\/p>\n Here we demonstrate insights from three years of research and real-world application<\/p>\n Method<\/strong><\/p>\n Clinical studies and real-world data analysis from hospitals and HMO home ultrasound services have been summarized and presented here.<\/p>\n Results<\/strong><\/p>\n Several studies have validated the Pulsenmore device’s feasibility, safety, and user acceptance. A study with 100 pregnant women demonstrated its effectiveness in detecting fetal heartbeat, movement, and amniotic fluid volume (AFV), with high satisfaction. A pivotal multicenter study in the USA confirmed these results. Real-world data in Israel showed over 98% precision in detecting prenatal parameters across 170,000+ scans. In Germany, studies confirmed the device’s acceptance and image quality for assessing AFV and fetal heartbeat, showing high patient satisfaction and potential to reduce outpatient visits.<\/p>\n Validation studies confirmed the device’s reliability and accuracy in measuring fetal heart rate and maximal vertical pocket, as well as its capability to conduct remote Biophysical Profile tests for high-risk pregnancies.<\/p>\n The device’s potential was demonstrated in monitoring high-risk pregnancies, reducing anxiety and ER visits for women with previous pregnancy loss, and managing gestational diabetes. Real-world utilization data indicate successful home admission of women with high-risk pregnancies.<\/p>\n Conclusion<\/strong><\/p>\n The Pulsenmore platform offers a safe, effective, and patient-centered solution for prenatal monitoring. Clinical evidence from three years of research and successful commercialization supports its integration into prenatal care.<\/p>\n","protected":false},"excerpt":{"rendered":" The Pulsenmore platform demonstrates strong clinical evidence for safety, efficacy, and usability in
\n1. Division of MFM, McGovern Medical School at UTHealth, Houston, TX
\n2. Division of Reproductive Endocrinology & Infertility, Koc Uni. Hospital, Istanbul
\n3. Dept. of OBGYN, East Virginia Medical School, Norfolk, VA
\n4. MFM, Beth Israel Deaconess Medical Center, Boston, MA
\n5. Center for Fetal & Maternal Ultrasound, UCLA School of Medicine, LA, CA
\n6. Dept. of MFM, Brigham & Women\u2019s Hospital, Boston, MA.
\n7. MFM, Icahn School of Medicine at Mount Sinai, NY
\n8. Pulsenmore LTD. Omer, Israel<\/span><\/p>\n
\nhome-based fetal well-being monitoring.<\/p>\n","protected":false},"author":11,"featured_media":58608,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":"","_links_to":"","_links_to_target":""},"categories":[147],"tags":[],"class_list":["post-58615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resumenes"],"yoast_head":"\n